Rachel King - Mar 29, 2023 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Director
Signature
/s/ Brian F. Leaf, Attorney-in-Fact
Stock symbol
GLYC
Transactions as of
Mar 29, 2023
Transactions value $
$10,002
Form type
4
Date filed
4/2/2024, 04:05 PM
Previous filing
Feb 6, 2023
Next filing
May 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common Stock Award $10K +3.33K +0.65% $3.00 515K Mar 29, 2024 Direct F1
holding GLYC Common Stock 7.5K Mar 29, 2023 By RBK LLC F2
holding GLYC Common Stock 90.7K Mar 29, 2023 By trusts F3
holding GLYC Common Stock 45.7K Mar 29, 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares will be issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of board and committee retainer fees of $10,000.
F2 The reporting person is co-manager of this entity. She disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
F3 These shares are held by family trusts, for which Ms. King serves as trustee, as follows: 1,741 shares are held by The Langley C. King 1990 Trust, 8,796 shares are held by the 1995 Connor A. King Trust, 8,796 shares are held by the 1995 Langley C. King Trust, 23,301 shares are held by The Connor King 2013 GRAT, 23,301 shares are held by The Langley C. King 2013 GRAT and 24,725 shares are held by The Rachel K. King 2016 GRAT. The total amount excludes 1,741 shares that were previously held by the Connor A. King 1988 Trust, as the trust has terminated and the shares are not beneficially owned by the reporting person.